缺氧诱导的PPFIA4通过糖代谢重编程加速卵巢癌的进展
1Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Nangang District, Harbin City, 150081, Heilongjiang Province, China.
Medical oncology (Northwood, London, England)
|August 18, 2023
概括
缺氧通过重编程葡萄糖代谢来促进卵巢癌的生长和转移. 向利prin-alpha-4 (PPFIA4) 抑制了这一过程,并可能为卵巢癌提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 卵巢癌表现出失调的葡萄糖分解,这是促进瘤生长和转移的关键代谢特征.
- 低氧是卵巢癌进展的重要因素,影响细胞代谢和行为.
研究的目的:
- 在低氧条件下的卵巢癌细胞中调解葡萄糖代谢重编程中,研究林-α-4 (PPFIA4) 的作用.
- 探索PPFIA4影响卵巢癌细胞活力,迁移,入侵和代谢适应缺氧的机制.
主要方法:
- 生物信息分析以确定PPFIA4作为低氧相关基因.
- 在体外测试包括CCK-8,Transwell,Western Blot,以评估细胞活力,迁移和入侵.
- 代谢分析测量葡萄糖摄取量,乳酸盐生产,ECAR,ATP,ROS,NADP/NADP+和OCR.
主要成果:
- 低氧增强了卵巢癌细胞的迁移,入侵和葡萄糖代谢重编程.
- PPFIA4的敲击抑制了卵巢癌细胞的活力,迁移,入侵,并逆转了缺氧诱导的代谢变化.
- 发现PPFIA4与缺氧诱导因子1alpha (HIF1A) 结合并受到上调.
结论:
- 通过HIF1A调节PPFIA4的升高促进了卵巢癌细胞在低氧状态下的葡萄糖代谢重编程.
- PPFIA4在低氧驱动的卵巢癌进展中发挥着关键作用.
- PPFIA4代表了卵巢癌干预的潜在治疗标.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Glucose Homeostasis: Regulation of Blood Glucose
1.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K


